HRT Financial’s iShares iBonds Dec 2025 Term Corporate ETF IBDQ Stock Holding History

HRT Financial’s Portfolio IBDQ Stock Details IBDQ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-36,612	Closed	-$922K	–	3543
2025 Q3	$922K	Buy	36,612 +8,213	+29%	+$206K	﹤0.01%	1564
2025 Q2	$715K	Buy	+28,399	New	+$713K	﹤0.01%	1425
2024 Q4	–	Sell	-37,687	Closed	-$945K	–	2769
2024 Q3	$945K	Buy	+37,687	New	+$941K	﹤0.01%	1265

Other funds holding IBDQ

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Mercer Global Advisors Denver, Colorado $67.6B AUM 18.3% 1-Year Est. Return

Balentine LLC Atlanta, Georgia $2.48B AUM 17.44% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

HRT Financial's IBDQ Position: Q4 2025 in Review

HRT Financial sold out of iShares iBonds Dec 2025 Term Corporate ETF (IBDQ) in Q4 2025, closing a stake of 36,612 shares — an estimated $922K sold.

HRT Financial first reported a position in IBDQ in Q3 2024 and held it in 3 quarters. The position peaked at $945K in Q3 2024. 3 funds tracked by Wall St. Rank hold IBDQ as of Q4 2025.

HRT Financial reported no remaining iShares iBonds Dec 2025 Term Corporate ETF position as of Q4 2025 after selling out during the quarter.
HRT Financial sold 36,612 iShares iBonds Dec 2025 Term Corporate ETF shares in Q4 2025, an estimated $922K.
HRT Financial first reported a position in iShares iBonds Dec 2025 Term Corporate ETF in Q3 2024 and held it in 3 quarters.
HRT Financial's iShares iBonds Dec 2025 Term Corporate ETF position peaked at $945K in Q3 2024.
3 funds tracked by Wall St. Rank held iShares iBonds Dec 2025 Term Corporate ETF as of Q4 2025.

Based on HRT Financial's 13F filing for Q4 2025, filed 12 Feb 2026.